Safety and effectiveness of pembrolizumab monotherapy in Japanese patients with unresectable urothelial carcinoma: a nation-wide post-marketing surveillance

BACKGROUND: This study was conducted to identify factors associated with the safety and effectiveness of pembrolizumab in Japanese patients with unresectable urothelial carcinoma and to confirm the real-world safety and effectiveness of pembrolizumab in Japanese patients. METHODS: This multicenter,...

Descripción completa

Detalles Bibliográficos
Autores principales: Nishiyama, Hiroyuki, Tanaka, Yu, Hamada, Masahiro, Ozaki, Masahiko, Minegishi, Toshihiko, Ito, Yuichiro, Maekawa, Shinichiroh, Yamamoto, Nobuyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10280973/
https://www.ncbi.nlm.nih.gov/pubmed/37340317
http://dx.doi.org/10.1186/s12885-023-10930-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10280973/
https://www.ncbi.nlm.nih.gov/pubmed/37340317
http://dx.doi.org/10.1186/s12885-023-10930-2

Ejemplares similares